Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its ...

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

The agency published the information online on Friday, along with the National Advisory Committee on Immunization's COVID-19 vaccine guidance for 2025 through to the summer of 2026. NACI ...

Moderna MRNA provided an update on its financial outlook and pipeline progress at the J.P. Morgan Healthcare Conference. At ...

A Food and Drug Administration (FDA ... especially due to COVID-19. The draft guidance is not legally binding and applies only to pulse oximeters used in hospitals and other medical settings.

Why These 5 Stocks Are On Investors' Radars Today Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table FDA Set To Approve COVID-19 Vaccines As Soon ...

2 strain of SARS-CoV-2, the virus that causes COVID. Spikevax, the COVID-19 vaccine manufactured by Moderna and FDA-approved for people 12 and older, is pictured in this undated photo. While the ...

A pharmaceutical company sued a lawmaker, saying he spread unfounded claims that its COVID-19 vaccine was a “bioweapon” and compared the firm to the notorious Unit 731 from World War II.